Empirical treatment of candidemia in intensive care units: Fluconazole or broad-spectrum antifungal agents?

By Guinea Jesus   Pelaez Teresa   Rodriguez-Creixems Marta   Torres-Narbona Marta   Munoz Patricia   Alcala Luis   Bouza Emilio  

Medical Mycology, Vol. 47, Iss. 5, 2008-10 ,pp. : 515-520

Informa Healthcare

Access to resources Recommend Favorite

In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital

By Arikan Sevtap   Sancak Banu   Hascelik Gulsen  

Medical Mycology, Vol. 43, Iss. 2, 2005-03 ,pp. : 171-178

Informa Healthcare

Access to resources Recommend Favorite

Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials

By Paphitou Niki   Ostrosky-Zeichner Luis   Rex John  

Medical Mycology, Vol. 43, Iss. 3, 2005-05 ,pp. : 235-243

Informa Healthcare

Access to resources Recommend Favorite

Epidemiology, presentation, management and outcome of candidemia in a tertiary care teaching hospital in the United Arab Emirates, 1995-2001

By Ellis Michael   Hedstrom Ulla   Jumaa Pauline   Bener Abdulbari  

Medical Mycology, Vol. 41, Iss. 6, 2003-12 ,pp. : 521-528

Informa Healthcare

Access to resources Recommend Favorite

Species distribution and in vitro antifungal susceptibility of clinical Candida isolates from a university hospital in Turkey over a 5-year period

By Kiraz Nuri   Oz Yasemin  

Medical Mycology, Vol. 49, Iss. 2, 2011-02 ,pp. : 126-131

Informa Healthcare

Access to resources Recommend Favorite